Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 752

1.

Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk.

Ait-Oufella H, Libby P, Tedgui A.

Arterioscler Thromb Vasc Biol. 2019 Jul 11:ATVBAHA119311998. doi: 10.1161/ATVBAHA.119.311998. [Epub ahead of print]

PMID:
31294625
2.

Low-Density Lipoprotein Cholesterol After an Acute Coronary Syndrome: How Low to Go?

Qamar A, Libby P.

Curr Cardiol Rep. 2019 Jun 27;21(8):77. doi: 10.1007/s11886-019-1160-6. Review.

PMID:
31250329
3.

Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology.

Ketelhuth DFJ, Lutgens E, Bäck M, Binder CJ, Van den Bossche J, Daniel C, Dumitriu IE, Hoefer I, Libby P, O'Neill L, Weber C, Evans PC.

Cardiovasc Res. 2019 Jul 1;115(9):1385-1392. doi: 10.1093/cvr/cvz166.

PMID:
31228191
4.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

5.

c-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells.

Shikatani EA, Besla R, Ensan S, Upadhye A, Khyzha N, Li A, Emoto T, Chiu F, Degousee N, Moreau JM, Perry HM, Thayaparan D, Cheng HS, Pacheco S, Smyth D, Noyan H, Zavitz CCJ, Bauer CMT, Hilgendorf I, Libby P, Swirski FK, Gommerman JL, Fish JE, Stampfli MR, Cybulsky MI, Rubin BB, Paige CJ, Bender TP, McNamara CA, Husain M, Robbins CS.

Cell Rep. 2019 May 21;27(8):2304-2312.e6. doi: 10.1016/j.celrep.2019.04.090.

6.

Targeting RNA to lower triglycerides: long strides from short molecules.

Qamar A, Libby P, Bhatt DL.

Eur Heart J. 2019 May 15. pii: ehz321. doi: 10.1093/eurheartj/ehz321. [Epub ahead of print] No abstract available.

PMID:
31089714
7.

Leaders in Cardiovascular Research: Peter Libby.

Guzik TJ, Libby P.

Cardiovasc Res. 2019 May 1;115(6):e61-e62. doi: 10.1093/cvr/cvz069. No abstract available.

PMID:
31077586
8.

Johann Sebastian Bach.

Libby P.

Circ Res. 2019 Apr 26;124(9):1303-1308. doi: 10.1161/CIRCRESAHA.119.315025. No abstract available.

PMID:
31021721
9.

Dietary cholesterol is essential to mast cell activation and associated obesity and diabetes in mice.

Zhang X, Huang Q, Wang X, Deng Z, Li J, Yan X, Jauhiainen M, Metso J, Libby P, Liu J, Shi GP.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1690-1700. doi: 10.1016/j.bbadis.2019.04.006. Epub 2019 Apr 9.

PMID:
30978390
10.

Modulating Adaptive Immunity in Vascular Disease: CD4 to the Fore.

Libby P, Lichtman AI.

J Am Coll Cardiol. 2019 Apr 16;73(14):1824-1826. doi: 10.1016/j.jacc.2019.01.050. No abstract available.

PMID:
30975300
11.

Arson in the artery: Who set the atheroma aflame?

Libby P.

Trends Cardiovasc Med. 2019 Mar 28. pii: S1050-1738(19)30043-X. doi: 10.1016/j.tcm.2019.03.006. [Epub ahead of print]

PMID:
30956033
12.

Arterial Inflammation: The Heat Before the Storm.

Blankstein R, Libby P, Bhatt DL.

J Am Coll Cardiol. 2019 Apr 2;73(12):1383-1385. doi: 10.1016/j.jacc.2019.02.002. No abstract available.

PMID:
30922469
13.

Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology.

Libby P, Kobold S.

Cardiovasc Res. 2019 Apr 15;115(5):824-829. doi: 10.1093/cvr/cvz058.

PMID:
30830168
14.

Novel Antiatherosclerotic Therapies.

Libby P, Everett BM.

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):538-545. doi: 10.1161/ATVBAHA.118.310958.

PMID:
30816799
15.

Once more unto the breach: endothelial permeability and atherogenesis.

Libby P.

Eur Heart J. 2019 Mar 14;40(11):938-940. doi: 10.1093/eurheartj/ehz081.

PMID:
30805590
16.

Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis.

Garbern JC, Williams J, Kristl AC, Malick A, Rachmin I, Gaeta B, Ahmed N, Vujic A, Libby P, Lee RT.

J Mol Cell Cardiol. 2019 Mar;128:179-186. doi: 10.1016/j.yjmcc.2019.01.018. Epub 2019 Feb 11.

PMID:
30763587
17.

Sleep modulates haematopoiesis and protects against atherosclerosis.

McAlpine CS, Kiss MG, Rattik S, He S, Vassalli A, Valet C, Anzai A, Chan CT, Mindur JE, Kahles F, Poller WC, Frodermann V, Fenn AM, Gregory AF, Halle L, Iwamoto Y, Hoyer FF, Binder CJ, Libby P, Tafti M, Scammell TE, Nahrendorf M, Swirski FK.

Nature. 2019 Feb;566(7744):383-387. doi: 10.1038/s41586-019-0948-2. Epub 2019 Feb 13.

PMID:
30760925
18.

Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease.

He S, Kahles F, Rattik S, Nairz M, McAlpine CS, Anzai A, Selgrade D, Fenn AM, Chan CT, Mindur JE, Valet C, Poller WC, Halle L, Rotllan N, Iwamoto Y, Wojtkiewicz GR, Weissleder R, Libby P, Fernández-Hernando C, Drucker DJ, Nahrendorf M, Swirski FK.

Nature. 2019 Feb;566(7742):115-119. doi: 10.1038/s41586-018-0849-9. Epub 2019 Jan 30.

PMID:
30700910
19.

Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis.

Vromman A, Ruvkun V, Shvartz E, Wojtkiewicz G, Santos Masson G, Tesmenitsky Y, Folco E, Gram H, Nahrendorf M, Swirski FK, Sukhova GK, Libby P.

Eur Heart J. 2019 Jan 30. doi: 10.1093/eurheartj/ehz008. [Epub ahead of print]

PMID:
30698710
20.

Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis.

Anzai A, Mindur JE, Halle L, Sano S, Choi JL, He S, McAlpine CS, Chan CT, Kahles F, Valet C, Fenn AM, Nairz M, Rattik S, Iwamoto Y, Fairweather D, Walsh K, Libby P, Nahrendorf M, Swirski FK.

J Exp Med. 2019 Feb 4;216(2):369-383. doi: 10.1084/jem.20180722. Epub 2019 Jan 22.

PMID:
30670465
21.

Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction.

Wang Y, Liu CL, Fang W, Zhang X, Yang C, Li J, Liu J, Sukhova GK, Gurish MF, Libby P, Shi GP, Zhang J.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1170-1181. doi: 10.1016/j.bbadis.2019.01.011. Epub 2019 Jan 11.

PMID:
30639224
22.

Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?

Marx N, Libby P.

JACC Basic Transl Sci. 2018 Dec 31;3(6):858-860. doi: 10.1016/j.jacbts.2018.11.008. eCollection 2018 Dec. No abstract available.

23.

Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.

Yu M, Ortega CA, Si K, Molinaro R, Schoen FJ, Leitao RFC, Xu X, Mahmoudi M, Ahn S, Liu J, Saw PE, Lee IH, Brayner MMB, Lotfi A, Shi J, Libby P, Jon S, Farokhzad OC.

Theranostics. 2018 Nov 15;8(21):6008-6024. doi: 10.7150/thno.24365. eCollection 2018.

24.

Reassessing the Mechanisms of Acute Coronary Syndromes.

Libby P, Pasterkamp G, Crea F, Jang IK.

Circ Res. 2019 Jan 4;124(1):150-160. doi: 10.1161/CIRCRESAHA.118.311098.

PMID:
30605419
25.

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.

Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM.

Circulation. 2019 Mar 5;139(10):1289-1299. doi: 10.1161/CIRCULATIONAHA.118.038010.

PMID:
30586730
26.

Jak-ing Up the Plaque's Lipid Core…and Even More.

Libby P, Molinaro R, Sellar RS, Ebert BL.

Circ Res. 2018 Nov 9;123(11):1180-1182. doi: 10.1161/CIRCRESAHA.118.314074. No abstract available.

PMID:
30571474
27.

Fish Oil and Perioperative Bleeding.

Akintoye E, Sethi P, Harris WS, Thompson PA, Marchioli R, Tavazzi L, Latini R, Pretorius M, Brown NJ, Libby P, Mozaffarian D.

Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004584. doi: 10.1161/CIRCOUTCOMES.118.004584.

PMID:
30571332
28.

CHIPping Away at the Pathogenesis of Heart Failure.

Libby P, Jaiswal S, Lin AE, Ebert BL.

JAMA Cardiol. 2018 Dec 19. doi: 10.1001/jamacardio.2018.4039. [Epub ahead of print] No abstract available.

PMID:
30566187
29.

Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review.

Gallone G, Baldetti L, Pagnesi M, Latib A, Colombo A, Libby P, Giannini F.

J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2886-2903. doi: 10.1016/j.jacc.2018.09.052. Review.

PMID:
30522652
30.

Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction.

Fang W, He A, Xiang MX, Lin Y, Wang Y, Li J, Yang C, Zhang X, Liu CL, Sukhova GK, Barascuk N, Larsen L, Karsdal M, Libby P, Shi GP.

J Mol Cell Cardiol. 2019 Feb;127:44-56. doi: 10.1016/j.yjmcc.2018.11.010. Epub 2018 Nov 19.

PMID:
30465799
31.

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.

Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ; CIRT Investigators.

N Engl J Med. 2019 Feb 21;380(8):752-762. doi: 10.1056/NEJMoa1809798. Epub 2018 Nov 10.

PMID:
30415610
32.

IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.

Wang J, Cheng X, Xiang MX, Alanne-Kinnunen M, Wang JA, Chen H, He A, Sun X, Lin Y, Tang TT, Tu X, Sjöberg S, Sukhova GK, Liao YH, Conrad DH, Yu L, Kawakami T, Kovanen PT, Libby P, Shi GP.

J Clin Invest. 2018 Nov 1;128(11):5184. doi: 10.1172/JCI124107. Epub 2018 Nov 1. No abstract available.

33.

CHIP (Clonal Hematopoiesis of Indeterminate Potential).

Libby P, Ebert BL.

Circulation. 2018 Aug 14;138(7):666-668. doi: 10.1161/CIRCULATIONAHA.118.034392. No abstract available.

PMID:
30359133
34.

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.

Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM.

Am Heart J. 2018 Dec;206:80-93. doi: 10.1016/j.ahj.2018.09.011. Epub 2018 Sep 29. Review.

35.

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, Hasan AA, Amar S.

J Am Coll Cardiol. 2018 Oct 23;72(17):2071-2081. doi: 10.1016/j.jacc.2018.08.1043. Review.

PMID:
30336831
36.

Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.

Solomon DH, Glynn RJ, MacFadyen JG, Libby P, Thuren T, Everett BM, Ridker PM.

Ann Intern Med. 2018 Oct 16;169(8):535-542. doi: 10.7326/M18-1167. Epub 2018 Sep 18.

PMID:
30242335
37.

Internal Bleeding: Is Intraplaque Hemorrhage a Decoration or a Driver?

Michel JB, Libby P, Franck G.

JACC Basic Transl Sci. 2018 Aug 28;3(4):481-484. doi: 10.1016/j.jacbts.2018.04.002. eCollection 2018 Aug. No abstract available.

38.

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).

Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, Koenig W, Shimokawa H, Everett BM, Glynn RJ.

Eur Heart J. 2018 Oct 7;39(38):3499-3507. doi: 10.1093/eurheartj/ehy310.

PMID:
30165610
39.

Partnerships Promote Translation in Biomedicine.

Libby P.

JACC Basic Transl Sci. 2018 Jun 25;3(3):431-433. doi: 10.1016/j.jacbts.2018.05.001. eCollection 2018 Jun. No abstract available.

40.

Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1α and Cathepsin G.

Folco EJ, Mawson TL, Vromman A, Bernardes-Souza B, Franck G, Persson O, Nakamura M, Newton G, Luscinskas FW, Libby P.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1901-1912. doi: 10.1161/ATVBAHA.118.311150.

PMID:
29976772
41.

Biologically-Based Therapies for Aortic Diseases: Why the Long Lag in Translation?

Libby P.

J Am Coll Cardiol. 2018 Jul 3;72(1):58-61. doi: 10.1016/j.jacc.2018.05.005. No abstract available.

42.

Atherosclerosis and inflammation: overview and updates.

Geovanini GR, Libby P.

Clin Sci (Lond). 2018 Jun 21;132(12):1243-1252. doi: 10.1042/CS20180306. Print 2018 Jun 29. Review.

PMID:
29930142
43.

Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers.

Ebert BL, Libby P.

Ann Intern Med. 2018 Jul 17;169(2):116-117. doi: 10.7326/M18-0737. Epub 2018 May 29. No abstract available.

PMID:
29809241
44.

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.

Ridker PM, MacFadyen JG, Glynn RJ, Koenig W, Libby P, Everett BM, Lefkowitz M, Thuren T, Cornel JH.

J Am Coll Cardiol. 2018 May 29;71(21):2405-2414. doi: 10.1016/j.jacc.2018.03.490.

45.

Association between Obstructive Sleep Apnea and Cardiovascular Risk Factors: Variation by Age, Sex, and Race. The Multi-Ethnic Study of Atherosclerosis.

Geovanini GR, Wang R, Weng J, Jenny NS, Shea S, Allison M, Libby P, Redline S.

Ann Am Thorac Soc. 2018 Aug;15(8):970-977. doi: 10.1513/AnnalsATS.201802-121OC.

PMID:
29742365
46.

The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial.

Solomon DH, Libby P, Yeomans ND, Wang Q, Wolski KE, Nissen SE, Husni ME.

Rheumatology (Oxford). 2018 Aug 1;57(8):1364-1369. doi: 10.1093/rheumatology/key105.

PMID:
29688503
47.

Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials.

Liu CL, Guo J, Zhang X, Sukhova GK, Libby P, Shi GP.

Nat Rev Cardiol. 2018 Jun;15(6):351-370. doi: 10.1038/s41569-018-0002-3. Review.

PMID:
29679024
48.

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.

Reed GW, Abdallah MS, Shao M, Wolski K, Wisniewski L, Yeomans N, Lüscher TF, Borer JS, Graham DY, Husni ME, Solomon DH, Libby P, Menon V, Lincoff AM, Nissen SE.

J Am Coll Cardiol. 2018 Apr 24;71(16):1741-1751. doi: 10.1016/j.jacc.2018.02.036.

49.

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.

Yeomans ND, Graham DY, Husni ME, Solomon DH, Stevens T, Vargo J, Wang Q, Wisniewski LM, Wolski KE, Borer JS, Libby P, Lincoff AM, Lüscher TF, Bao W, Walker C, Nissen SE; PRECISION investigators.

Aliment Pharmacol Ther. 2018 Jun;47(11):1453-1463. doi: 10.1111/apt.14610. Epub 2018 Apr 17.

PMID:
29667211
50.

All roads lead to IL-6: A central hub of cardiometabolic signaling.

Libby P, Rocha VZ.

Int J Cardiol. 2018 May 15;259:213-215. doi: 10.1016/j.ijcard.2018.02.062. No abstract available.

PMID:
29579604

Supplemental Content

Support Center